Valuation : Pharma Foods International Co., Ltd.

Market Cap 17.28B 112M 96.36M 90.65M 82.73M 154M 10.62B 155M 1.07B 416M 5.43B 421M 412M P/E 2026 *
12.2x
P/E 2027 * 10.9x
Enterprise Value 17.28B 112M 96.36M 90.65M 82.73M 154M 10.62B 155M 1.07B 416M 5.43B 421M 412M EV / Sales 2026 *
0.26x
EV / Sales 2027 * 0.25x
Free-Float
66.91%
Yield 2026 *
4.2%
Yield 2027 * 5.04%
1 day+3.70%
1 week+2.66%
Current month+0.16%
1 month+6.93%
3 months-1.75%
6 months+7.87%
Current year-9.13%
1 week 584
Extreme 584
624
1 month 571
Extreme 571
625
Current year 513
Extreme 513
741
1 year 513
Extreme 513
1,064
3 years 513
Extreme 513
1,594
5 years 513
Extreme 513
2,817
10 years 340
Extreme 340
3,820
Manager TitleAgeSince
President 79 1999-10-31
Chief Administrative Officer 50 2022-07-31
Chief Tech/Sci/R&D Officer 45 2023-09-30
Director TitleAgeSince
Director/Board Member 71 2015-09-30
Director/Board Member 79 1999-10-31
Director/Board Member 50 2008-09-30
Change 5-day change 1-year change 3-year change Capi.($)
+3.70%+2.66%-40.79%-60.06% 112M
-0.82%-3.77%-2.49%+14.92% 48.01B
-1.29%-1.22%+404.92%+545.45% 44.44B
-3.20%+0.33%+38.11%+21.39% 42.67B
-1.89%-2.00%+1.45%+82.46% 39.96B
-1.72%-2.61%+13.09%+42.33% 32.75B
-0.17%+3.78% - - 17.74B
-0.07%+1.32%+20.08%+117.95% 16.49B
-0.56%-0.50%+11.39%+31.41% 14.38B
-2.68%-0.56%+73.31%+40.56% 13.4B
Average -0.87%-0.74%+57.67%+92.94% 26.99B
Weighted average by Cap. -1.53%-1.05%+85.09%+132.76%

Financials

2026 *2027 *
Net sales 66.63B 432M 372M 350M 319M 595M 40.96B 598M 4.14B 1.6B 20.94B 1.62B 1.59B 69.5B 451M 388M 365M 333M 621M 42.73B 624M 4.32B 1.67B 21.84B 1.69B 1.66B
Net income 1.42B 9.21M 7.92M 7.45M 6.8M 12.69M 873M 12.75M 88.26M 34.15M 446M 34.58M 33.82M 1.58B 10.25M 8.81M 8.29M 7.56M 14.12M 971M 14.19M 98.2M 37.99M 497M 38.48M 37.64M
Net Debt - -
Logo Pharma Foods International Co., Ltd.
Pharma Foods International Co Ltd is a Japan-based company mainly engaged in the development and sale of supplements, quasi-drugs, and functional food ingredients. It operates through three business segments. The Business-to-Consumer (B2C) segment sells supplements and quasi-drugs containing proprietary functional ingredients, and cosmetics, directly to consumers via mail order or wholesale to specialized shopping channels. The Business-to-Business (B2B) segment researches, develops, and manufactures functional ingredients, health foods, and pharmaceuticals, and sells them to food and pharmaceutical manufacturers, distributors, and others. The Biomedical segment is engaged in research and development of intractable diseases such as autoimmune diseases, cancer, and inflammatory diseases, and research support services that provide contract proteome analysis. Other businesses include venture capital, investment, solar power generation, food and beverage businesses, and others.
Employees
613
Date Price Change Volume
26-09-09 JP¥617.00 +3.70% 436,500
26-09-08 JP¥595.00 -1.98% 110,200
26-09-07 JP¥607.00 -0.49% 101,700
26-09-04 JP¥610.00 +1.33% 93,500
26-09-03 JP¥602.00 +0.17% 140,600

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2929 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!